Canfield has been providing real and near-real time advanced imaging services and products to the Pharmaceutical, Device, Biologic, and Cosmetic industries for 20 years.

We offer customized solutions that extract quantitative information from images to provide your clinical research, or product efficacy studies, a competitive and scientific edge. Imaging data produced in our 21 CFR Part 11 compliant environment are routinely submitted to the FDA and regulatory authorities worldwide in support of both new drug applications and advisory panel meetings.

When used in conjunction with our 2D & 3D standardized photographic equipment, Canfield can deliver quantitative data for use in new drug applications, claims substantiations, publications, promotions, and sales and marketing.